{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:53:05Z","timestamp":1792569185315,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.chest.2024.04.036","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T15:57:03Z","timestamp":1717430223000},"page":"867-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Clinical and Economic Implications of Different Treatment Pathways for Patients With Rapidly Recurrent Malignant Pleural Effusion"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6351-5552","authenticated-orcid":false,"given":"David E.","family":"Ost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6075-3088","authenticated-orcid":false,"given":"Claudia","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2598-3133","authenticated-orcid":false,"given":"Molly","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4853-7811","authenticated-orcid":false,"given":"Ashley","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9441-5072","authenticated-orcid":false,"given":"Erik","family":"Erdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 10","key":"10.1016\/j.chest.2024.04.036_bib1","doi-asserted-by":"crossref","first-page":"S1111","DOI":"10.21037\/jtd.2017.07.79","article-title":"Diagnosis and management of malignant pleural effusions: state of the art in 2017","volume":"9","author":"Desai","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"issue":"4","key":"10.1016\/j.chest.2024.04.036_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.chest.2016.11.010","article-title":"US hospitalizations for malignant pleural effusions: data from the 2012 National Inpatient Sample","volume":"151","author":"Taghizadeh","year":"2017","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.chest.2024.04.036_bib3","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.201612-2405ED","article-title":"The evolving role of the indwelling tunneled pleural catheter. A means to an end","volume":"195","author":"Argento","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2024.04.036_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2024.04.036_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(15)00183-6","article-title":"Individualised management of malignant pleural effusion","volume":"3","author":"Clive","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.chest.2024.04.036_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/CMAR.S95663","article-title":"Management of malignant pleural effusion: challenges and solutions","volume":"9","author":"Penz","year":"2017","journal-title":"Cancer Manag Res"},{"issue":"4","key":"10.1016\/j.chest.2024.04.036_bib7","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.chest.2021.05.026","article-title":"Epidemiology of adult pleural disease in the United States","volume":"160","author":"Mummadi","year":"2021","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2024.04.036_bib8","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.21037\/tlcr-20-1111","article-title":"Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review","volume":"10","author":"Zhang","year":"2021","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"10.1016\/j.chest.2024.04.036_bib9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.chest.2021.11.031","article-title":"The frequency, risk factors, and management of complications from pleural procedures","volume":"161","author":"Sundaralingam","year":"2022","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2024.04.036_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/resp.12962","article-title":"Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion","volume":"22","author":"Olfert","year":"2017","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.chest.2024.04.036_bib11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.chest.2017.08.026","article-title":"Quality gaps and comparative effectiveness of management strategies for recurrent malignant pleural effusions","volume":"153","author":"Ost","year":"2018","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.chest.2024.04.036_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1524-4733.2009.00602.x","volume":"12","author":"Johnson","year":"2009","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.chest.2024.04.036_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cam4.1896","article-title":"Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare","volume":"8","author":"Sheehan","year":"2019","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.chest.2024.04.036_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/JOP.19.00061","article-title":"Patterns of care and costs for older patients with colorectal cancer at the end of life: descriptive study of the United States and Canada","volume":"16","author":"Bremner","year":"2020","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"10.1016\/j.chest.2024.04.036_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MCP.0b013e3283615b67","article-title":"Management of malignant pleural effusions: questions that need answers","volume":"19","author":"Davies","year":"2013","journal-title":"Curr Opin Pulm Med"},{"issue":"11","key":"10.1016\/j.chest.2024.04.036_bib16","first-page":"5131","article-title":"Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results","volume":"32","author":"Basso","year":"2012","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.chest.2024.04.036_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.chest.2024.04.036_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000285","article-title":"Global cancer control: responding to the growing burden, rising costs and inequalities in access","volume":"3","author":"Prager","year":"2018","journal-title":"ESMO Open"},{"issue":"22","key":"10.1016\/j.chest.2024.04.036_bib19","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs\u00a0chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.chest.2024.04.036_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.127.3.909","article-title":"Phase III intergroup study of talc poudrage vs\u00a0talc slurry sclerosis for malignant pleural effusion","volume":"127","author":"Dresler","year":"2005","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.chest.2024.04.036_bib21","doi-asserted-by":"crossref","first-page":"975","DOI":"10.6004\/jnccn.2012.0102","article-title":"Optimal management of malignant pleural effusions (results of CALGB 30102)","volume":"10","author":"Demmy","year":"2012","journal-title":"J\u00a0Natl Compr Canc Netw"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224006846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224006846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T22:19:48Z","timestamp":1730326788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369224006846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0012369224006846"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2024.04.036","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical and Economic Implications of Different Treatment Pathways for Patients With Rapidly Recurrent Malignant Pleural Effusion","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2024.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}